Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib.

This study is currently recruiting participants.

Study NCT00503971 Information provided by Spanish Lung Cancer Group

First Received: July 18, 2007 Last Updated: April 4, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	September 2010
Estimated Primary Completion Date:	December 2008 (Final data collection date for primary outcome measure)